company? Let’s change
that.
Don't see your company?
Create a company profileClick Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click’s platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. NOTE: Fake job advertisements and offers are increasingly appearing on the internet. If you have encountered a job posting or have been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond and report it to the Federal Trade Commission and to [email protected]. Other than your email address or telephone number, which you may provide via a job application portal, Click Therapeutics will never ask you to provide personally identifiable information about yourself (such as a Social Security Number or Driver’s License Number) via a messaging application.
Biorasi is a customer-focused, full-service, contract research organization (CRO) that delivers fast and flexible solutions across global clinical trials to maximize speed-to-market for its sponsors. As the leader in neurology, nephrology, dermatology, and the rare and urgent disease market, Biorasi sets new standards for speed, agility, and quality in patient enrollment, decentralized trials, and data transparency. It is Biorasi’s mission to be a catalyst for growth, innovation, and evolution in the field of clinical research – moving the industry forward while improving results for our partners and outcomes for their patients. Our culture is based on our strong commitment to building true partnerships with our sponsors. We approach all of our trials with urgency, commitment, and resolve. Established in 2002, Biorasi is headquartered in Aventura, FL, with office-based teams around the globe. From its regional presences, Biorasi is able to directly support studies in the Americas, Europe, and APAC. We have received multiple accolades including placement in the INC 500 and 5000 list of fastest-growing companies in America, Frost and Sullivan’s Entrepreneurial Company of the Year for the CRO Industry, and the CRO Leadership Award from Life Science Leader magazine.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with our customers, we are driven to make healthcare better.
Biscayne Pharmaceuticals discovers and develops novel therapies based on growth hormone-releasing hormone (GHRH) analogs.
Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients. Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.
Welcome to Curallux, the leading ISO-13485 certified US manufacturer of photobiomodulating medical devices under the Capillus® and Curavi® brands. Capillus laser light devices are FDA-cleared for the treatment of hair loss with clinically proven technology trusted by hair restoration physicians worldwide. The company, which revolutionized the hair restoration industry, has now entered the field of pain management with Curavi®, an effective non-pharmaceutical solution to treat pain with laser light.
Vivex Biomedical is a biomedical company developing implant technology and stem cell therapies.
OrganaBio is a Miami-based CDMO that manufactures clinical (cGMP) grade cells for cancer immunotherapy and regenerative medicine drug developers. OrganaBio’s vision is to accelerate the development of these drugs by giving developers access to (i) fresh and scalable tissue supplies; (ii) cell isolation, purification, expansion, and characterization services; (iii) process development services; and (iv) clinical-grade manufacturing services. At OrganaBio, we empower our customers’ people, process, and products on their journey to commercialization. Our team is comprised of highly motivated individuals who thrive in a fast-paced environment and are adept (and like) to deal with different tasks within a workweek.
Genetic Networks provides comparable target and drug optimization insights that improve decision making.
At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.
Veru improve lives through innovative science and medicine as a leading biopharmaceutical company focused on urology and oncology.
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases.
Our team of scientists and engineers are working to evolve the water we drink to improve health from the inside out. The patented Weo biotechnology uses a unique form of electrolysis to amplify the health benefits in water, and is easily installed at home or used on-the-go–making augmented water available to everyone.
Biotechnology startup developing automated species identification technologies for AgTech, BioTech, and Environmental monitoring sectors.
Innovative Genetics is a pioneer in its segment of the biotechnology industry.
Progressive Care provides prescription pharmaceuticals specializing in anti-retroviral patient management, long-term care, and DME.
Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Halodine is a biopharmaceutical company focused on development of novel antiviral therapies.
Entopsis utilizes a proprietary material science screening platform to develop cost-effective and impactful products. Our leading solutions: 1) OpsisDx: universal platform to diagnose cancer and various diseases thru urine www.entopsis.com 2) PCRopsis: series of time & cost saving technologies for the life sciences
NextSource Biotechnology is a biotechnology and pharmaceutical company located in Miami.
Work Your Passion. Live Your Purpose.